The simultaneous measurement of the decrease of available Fe II and the increase of available Fe III allowed the analysis of the ferroxidase activity of two distinct apoferritins. Although recombinant human apoferritin (HuFtH) rapidly oxidizes Fe II to Fe III , this is not properly stored in the ferritin cavity, as occurs in horse spleen H/L-apoferritin (HsFt). Fe storage in these apoferritins was also studied in the presence of two Cu-loaded mammalian metallothioneins (MT2 and MT3), a scenario occurring in different brain cell types. For HuFtH, unstored Fe III triggers the oxidation of Cu-MT2 with concomitant Cu I release. In contrast, for HsFt, there is no reaction with Cu-MT2. Similarly, Cu-MT3 does not react during either HuFtH or HsFt Fe reconstitution. Significantly, the combination of ferritin and metallothionein isoforms reported in glia and neuronal cells are precisely those that avoid a harmful release of Fe II and Cu I ions.
100 thousands of Fe atoms as an Fe III mineral, often described as ferrihydrite, [Fe III 10O14(OH)2 ]. [5] There are two different types of monomer included in the 24 subunits which compose the Ft shell: the heavy (H) subunits, 178 amino acids and 21 kDa, and the light (L) subunits, 171 aminoacids and 19 kDa, and each have different functionality. Thus, whereas the H monomers play a key role in rapid Fe detoxification, because they contain a catalytic ferroxidase center for F e I I oxidation, the L subunits seem to be associated with Fe nucleation, mineralization and long-term Fe storage in the ferritin cavity. [2] In accordance with this, the H/L ratio in a ferritin shell varies widely in different organisms and different tissues, but it is worth noting that Ft proteins with a combination of H and L subunits are only found in vertebrates. In this subphylum, L-subunit-rich ferritins predominate in Fe storage organs such as the liver and spleen, whereas organs that require Fe detoxification, such as the heart and most brain cells, contain mostly H-rich ferritins. As an example, horse spleen Ft contains about 90% L-and 10% H-subunits. In bacteria, plants and invertebrates, ferritins are exclusively composed of H-like subunits.
To load apoferritin (apoFt), a Ft molecule that does not contain Fe, requires Fe II and not, Fe III as the substrate. In broad terms, it is accepted that Fe II moves through the hydrophilic channels until it finds the ferroxidase center of an Hsubunit, here it is catalytically oxidized to Fe III by reaction with cellular O 2 . It then moves to the cavity where it is finally stored as a ferrihydrite nanoparticle. [6] The mechanism of the ferroxidase oxidation of Fe II to Fe III , as well as the path of Fe III from the ferroxidase center to the cavity, are currently a point of controversy. [2, [6] [7] [8] [9] [10] In any case, if any Fe III remains at the ferroxidase center, somehow close to the surface of ferritin, some biomolecules could be able to scavenge it. In fact, Hagen et al. have shown that transferrin, a large protein (80 kDa) that is unable to enter the Ft cavity, scavenges the two Fe III ions of the ferroxidase center. [10] However, in these experiments transferrin just served as an Fe III sensor to confirm the nature of the ferroxidase center and the results have little biological relevance because Ft is basically intracellular, whereas transferrin is the plasma Fe III transport protein.
Considering this background, and with the aims of, (a) gaining further insight into the biological consequences of ferroxidase center function, and (b) correlating the apoferritin composition resulting Fe III unavailable, we decided to study how Fe II is oxidized by two apoFts with different H/L ratios: recombinant human H-apoFt (HuFtH), a homopolymer of 24 identical H-subunits each with a ferroxidase center, and the commonly studied horse spleen apoFt (HsFt), a heteropolymer formed of approximately 3 H-and 21 L-subunits (L-subunits lack the ferroxidase center). The Fe II to Fe III oxidation activities of HuFtH and HsFt, and their capacities to make the formed Fe III unavailable, were studied by following a very simple protocol. This was based on monitoring the decrease of available Hence, monitoring ([Fe II (fz) 3 ] 2+ ) concentration, i.e., recording the time dependence of A 562nm allows evaluation of the capability of each apoFt to oxidize Fe II because the faster is the Fe II oxidation process, the faster is the decrease of the UV-vis absorbance at 562 nm. As shown in Figure 1 , the free Fe II concentration decreases in the presence of HsFt (L-rich) to reach a plateau corresponding to a remaining 40% of the initial Fe II , while the decrease of free Fe II in the presence of HuFtH (entirely H-subunits) is significantly higher, so that within a few minutes almost all the initial Fe II is no longer available to react with fz. These results corroborate the idea that the ferroxidase activity of apoFt increases with its H/L ratio, as activity is clearly higher for HuFtH than for HsFt. According to previous reports on this subject, we cannot rule out the possibility of a small fraction of the initial Fe II being stabilized in the ferritin cavity and therefore unavailable for fz complexation. [11] However, the rapid increase of A 464nm due to the formation of Fe III -Lf in the presence of HuFtH confirms that for this protein, Fe II is not available for fz complexation because a large proportion of the initial Fe II is actually oxidized to Fe III rather than stabilized within the protein as Fe II . In either case, the presence or absence of a small fraction of stabilized Fe II within the ferritin cavity is neither the focus of this work nor is it crucial for the conclusions which wewill draw, our focus is on the presence/absence of available Fe III during the Ft mineralization process. In this context, our results clearly demonstrate that once Fe II is oxidized by HsFt, the resulting Fe III is in an inaccessible form, probably because these Fe III ions are stored inside the protein cavity and Lf is too large to pass through the Ft channels to bind Fe III . However, although HuFtH oxidizes practically all of the initial Fe II , half of the formed Fe III is available to large biomolecules such as Lf. Furthermore, according to our results and contrasting them with those reported by Hagen et al., [10] the amount of Fe III complexed by Lf during the Fe reconstitution process of HuFtH is almost double than that corresponding to the number of Fe atoms at the ferroxidase centers (24 x 2 per protein). Here, the protein is present in catalytic quantities, and therefore a large excess of Fe II has been added (a situation that is probably closer to the actual in vivo scenario) and so we can conclude that the target of Lf is probably not only the Fe III ions fixed at the ferroxidase centers but also the Fe III cations formed at such centers and which are not really stored by HuFtH within the protein cavity. This protein, therefore, conclusively exhibits high ferroxidase activity but a low Fe storage capacity. In contrast, HsFt exhibits low ferroxidase activity but with a high Fe III storage capacity since we did not observe Fe with Lf, thus indicating that although relatively little Fe III is formed, it is genuinely stored within the ferritin cavity (i.e., it is not available for a chelating agent). More interestingly, and in a second stage of this work, we focused on the biological relevance of our results by investigating some of the chemical consequences of the observed Fe III availability during reconstitution of Ft. We tried to go one step further beyond the demonstration that once Fe II has been oxidized at the ferroxidase center of Ft, some Fe III ions can then be scavenged by an Fe III chelator. If, according to the present results and those of Hagen et al., [10] Fe III produced in the Ft ferroxidase center is available for complexation by a large molecule such as transferrin, it should also be able to act as an oxidant against metallothioneins (MTs). [12] This possibility takes special relevance in view of the Fenton reactivity of Cu I/II ions and the widely assumed presence of Cu-containing MTs in brain cells. Bearing this in mind, we studied the Fe reconstitution of the two different ferritins from our study (HuFtH and HsFt) in the presence of the Cu-loaded forms of two mammalian MT isoforms (MT2 and MT3). MTs are small (6 -10 kDa) and cysteine rich (33%) metaloproteins. They are naturally found bound to either Zn II and/or Cu I but their biological function is still a matter of debate although they are accepted as major players in the homeostasis of physiological Zn and Cu . [13, 14] We paid particular attention to MT2 and MT3 because the former is predominantly synthesized in astrocytes and microglia, where ferritin is mainly found in the Lrich form, while the latter is a brain-specific isoform constitutively expressed in neurons, where H-rich ferritins are predominant. [15, 16] Therefore, the coexistence of certain combinations of Ft and MT (i.e., MT2 with L-rich or MT3 with H-rich ferritins) can be considered to be a direct reflection of the situation encountered in different types of brain cells. In accordance with the Zn-thionein character of MT2 [17] and the partial Cu-thionein character of MT3, [18, 19] [20] which is the closest approximation to mammalian cell conditions. They yielded a mixture of Zn 1 Cu 10 -and Zn 2 Cu 10 -as major species for MT2 [17] and a mixture of Zn 4 Cu 6-and Cu 10complexes for MT3 [18] , which from now on and for the sake of simplicity we shall refer to as the Cu-MT2 and Cu-MT3 complexes.
For these experiments, we prepared a batch of Fe II -apoFt mixtures with HsFt and with HuFtH, and allowed them to react aerobically for 15 minutes. These When HuFtH is incubated with Fe II and after 15 min of reaction (once the Fe II oxidation is almost complete, Figure 1 ) Cu-MT2 -together with fz-is added to the reaction mixture, the ([Fe II (fz) 3 ] 2+ ) complex forms and its concentration increases with time ( Figure 3 ). This final experiment evidences that after the reduction of the Fe II concentration to almost zero during the Fe reconstitution process of HuFtH, reaction upon addition of Cu-MT2 again raises the Fe II concentration to 59% of the initial value as a consequence of the oxidation of MT2 by Fe III .
In summary, in this paper we demonstrate that part of the Fe III formed at the ferroxidase centers of HuFtH is available, not only for complexation with an Fe III chelator, but also to oxidize Cu-loaded MT2, giving rise to the concomitant release of two toxic metals ions, Cu I and Fe II . The latter reaction does not take place when the apoferritin is a H/L heteropolymer such as HsFt. In this case, all the Fe III formed at the ferroxidase center is unavailable for either Lf complexation or MT oxidation. The chemical scenario we have created is especially significant in the brain, where incorrect Fe uptake by Ft has been suggested to result in the progression of neurological diseases. Hence, Dobson and co-workers proposed that patients with Alzheimer's disease could have a dysfunction in brain Fe storage due to a disruption in the balance of ferritin Hand L-subunit synthesis. [21] In this sense, our results point out that in cells where Cu-MT2 and Ft coexist, there is no danger if the ferritin is L-rich, as it occurs in astrocytes and microglia, [16] and both proteins would preserve their integrity and functionality. However, if this imbalance in L-and H-subunit synthesis leads to the synthesis of pure H apoferritins, and therefore to some events analogous to those we have described here in which the high ferroxidase activity and low Fe storage capacity of a H-rich Ft would provoke Cu I liberation from Cu-MT2, then the presence of two free and toxic metals such as Cu I and Fe II , could produce fatal results for the cell. Interestingly, Cu-MT3 does not react with either HuFtH or HsFt in the presence of Fe II thus making the Cu-MT3 and Ft pair a nondeleterious combination in neurons. This is extremely relevant because in neuron cells Ft is mainly present in H-rich forms, [16] which would lead to a harmful interaction should the predominant MT isoform present be that of MT2. What we wish to underline here is that the process of Fe storage in ferritin affects parallel metal metabolisms depending on the protein shell itself. Following on from that we have shown that an excessive proportion of H-subunits in the ferritin shell results in a significant decrease in the amount of Fe stored, meaning that there is free Fe III available that is capable of oxidizing Cu-MT2, ultimately leading to the liberation of toxic Fe II and Cu I . As a final conclusion, it is worth highlighting that the current results reconcile the simultaneous presence of ferritins and MT in cells, [12] provided that the correct combination of isoforms is preserved, otherwise metal-related neuronal disorders could be triggered if parting from this ideal combination.
Experimental Section
Materials. Horse spleen apoFt (HsFt) was obtained from Sigma and was exhaustively dialyzed against Milli-Q water using a Spectra/Por Float-A-Lyzer with a molecular weight cut off (MWCO) of 300,000 Da. Recombinant human H-Ft (HuFtH) was prepared as previously described [21, 22] and rendered iron free by dialysis against sodium hydrosulfite (dithionite), Na 2 S 2 O 4 , and complexation with 2,2'-bipyridyl at pH 6.0 [23] , to isolate an apoferritin containing 10 Fe/protein. The
Cu loaded forms of the mammalian metallothionein isoforms MT2 and MT3 were recombinantly synthesized and characterized (ICP-AES and ESI-MS) as previously reported. [17, 18] The final preparations were 0.13 x 10 -4 M (MT2) and 0.35 x 10 -4 M (MT3) in 50 mM Tris-HCl, pH 7.5 buffer, and they were deaerated under N 2 flux to avoid the presence of O 2 during the described reactions. Monoferric lactoferrin was purchased from Fonterra. Lf was prepared following the same protocol as reported previously. [24] Measurement of available Fe Measurement of Fe III reduction to Fe II during HuFtH ferritin reconstitution in the presence of Cu-MT2. The previous protocol was followed but using ferrozine instead of BTA as a chelating agent for the purposes of measuring the Fe II concentration. We noted that after 15 min of Fe II reconstitution by HuFtH, the Fe II concentration had dramatically decreased (Figure 1 ). Therefore the increase of Fe II concentration in this experiment corresponds to the oxidation of Cu-MT2
by Fe III with the subsequent formation of Fe II , which is ultimately detected and quantified by its complexation with fz.
Oxidation of Cu-MT by Fe

III
. In a parallel experiment, Cu-MT2 (100 µL, 3 µM) and
Cu-MT3 (100 µL, 3 µM) were incubated at 37 ºC in a degassed aqueous solution of Fe III acetate (0.02 mM) under Ar. BTA or fz was added to detect and quantify the Cu I or Fe II concentrations.
